Chicago Equity Partners’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $34K | Sell |
11,940
-170,570
| -93% | -$486K | ﹤0.01% | 642 |
|
|
2019
Q4 | $592K | Sell |
182,510
-336,805
| -65% | -$1.09M | 0.03% | 599 |
|
|
2019
Q3 | $1.12M | Sell |
519,315
-27,172
| -5% | -$58.7K | 0.05% | 460 |
|
|
2019
Q2 | $1.72M | Buy |
546,487
+442,247
| +424% | +$1.39M | 0.08% | 369 |
|
|
2019
Q1 | $388K | Hold |
104,240
| – | – | 0.02% | 724 |
|
|
2018
Q4 | $302K | Buy |
+104,240
| New | +$302K | 0.01% | 731 |
|
|
2018
Q1 | – | Sell |
-461,100
| Closed | -$1.26M | – | 851 |
|
|
2017
Q4 | $1.26M | Buy |
+461,100
| New | +$1.26M | 0.04% | 453 |
|
|
2014
Q4 | – | Sell |
-20,180
| Closed | -$150K | – | 510 |
|
|
2014
Q3 | $150K | Sell |
20,180
-9,670
| -32% | -$71.9K | ﹤0.01% | 435 |
|
|
2014
Q2 | $288K | Sell |
29,850
-1,525
| -5% | -$14.7K | 0.01% | 373 |
|
|
2014
Q1 | $260K | Buy |
31,375
+425
| +1% | +$3.52K | 0.01% | 405 |
|
|
2013
Q4 | $261K | Buy |
+30,950
| New | +$261K | 0.01% | 374 |
|